Hydrochloric Acid

Hydrochloric Acid

SCHEMBL648411

CC1=C([Zr+2](=C(C)C)c2cccc3c2Cc2ccccc2-3)C(C)C=C1.[Cl-].[Cl-]

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PNMT P11086 1/20 0.33
ALDH1A1 P00352 1/20 0.31
HTR7 P34969 1/20 0.30
HTR2B P41595 1/20 0.30
DRD2 P14416 1/20 0.30
DRD4 P21917 1/20 0.30
DRD3 P35462 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL820095 0.88 PNMT (0.33) NPC1RAB9APNMTDRD2DRD4
Hydrochloric Acid SCHEMBL3006006 0.81 NPC1 (0.37) NPC1RAB9APNMTHTR7HTR2B
Hydrochloric Acid SCHEMBL4481194 0.81 PNMT (0.33) NPC1RAB9APNMTDRD2DRD4
Hydrochloric Acid SCHEMBL3124487 0.81 NPC1 (0.49) NPC1RAB9APNMTALDH1A1HTR7
Hydrochloric Acid SCHEMBL676093 0.80 NPC1 (0.32) NPC1RAB9ADRD2
Hydrochloric Acid SCHEMBL674374 0.80 NPC1 (0.32) NPC1RAB9A
Hydrochloric Acid SCHEMBL6553935 0.80 NPC1 (0.38) NPC1RAB9APNMTHTR7HTR2B
Hydrochloric Acid SCHEMBL3015454 0.78 NPC1 (0.34) NPC1RAB9APNMT
Hydrochloric Acid SCHEMBL3005060 0.78 NPC1 (0.34) NPC1RAB9APNMTDRD2DRD4
Hydrochloric Acid SCHEMBL3011448 0.78 NPC1 (0.34) NPC1RAB9APNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8373011-B2 Used in a base oil of lubricant having good low temperature fluidity, low evaporativity, and thermal stability and oxidation stability IDEMITSU KOSAN CO., LTD. (JP) 2013-02-12 US disclosed
US-20120088946-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2012-04-12 US disclosed
US-8119850-B2 Process for producing unsaturated hydrocarbon compound IDEMITSU KOSAN CO., LTD. (JP) 2012-02-21 US disclosed
EP-0945471-B1 CATALYSTS FOR THE POLYMERIZATION OF OLEFINS, PROCESS FOR THE PRODUCTION OF OLEFIN POLYMERS, AND PROCESSES FOR THE PRODUCTION OF STYRENE POLYMERS IDEMITSU KOSAN CO (JP) 2009-05-13 EP disclosed
US-20090069614-A1 METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2009-03-12 US disclosed
US-20090030255-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2009-01-29 US disclosed
US-20080146469-A1 Process for producing saturated aliphatic hydrocarbon compound, and lubricant composition IDEMITSU KOSAN CO., LTD. (JP) 2008-06-19 US disclosed
EP-1880986-A1 PROCESS FOR PRODUCING SATURATED ALIPHATIC HYDROCARBON COMPOUND, AND LUBRICANT COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2008-01-23 EP disclosed
EP-1849757-A1 METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2007-10-31 EP disclosed
US-6787499-B2 Catalyst for the production of α-olefin and α-olefin production method IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2004-09-07 US disclosed
EP-0589638-A2 Powder catalyst composition and process for polymerizing olefins with the use thereof MITSUBISHI CHEMICAL CORPORATION (JP) 1994-03-30 EP disclosed
EP-0574258-A2 Process for producing alpha-olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1993-12-15 EP disclosed
EP-0570126-A1 Method for producing graft-modified copolymers MITSUBISHI CHEMICAL CORPORATION (JP) 1993-11-18 EP disclosed
EP-0566349-A2 Process for producing alpha-olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1993-10-20 EP disclosed
US-5252677-A Epoxy, hydroxy or sulfonic acid end groups MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) 1993-10-12 US disclosed
US-5225501-A Transition metal compound and alumoxane catalyst MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) 1993-07-06 US disclosed
EP-0512741-A1 Process for producing a propylene random copolymer MITSUBISHI CHEMICAL CORPORATION (JP) 1992-11-11 EP disclosed
EP-0511846-A1 Aminated olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1992-11-04 EP disclosed
EP-0498675-A2 Production of alpha-olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1992-08-12 EP disclosed
EP-0487278-A2 Functionalized olefin polymers MITSUBISHI CHEMICAL CORPORATION (JP) 1992-05-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030255-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND ALOX12, ALOX15B, ALOX15 NPC1 1027/4885RAB9A 4335/4885PNMT 1509/4885
US-20090069614-A1 METHOD FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND AHR, ALOX12, ARNT NPC1 684/4885RAB9A 4259/4885PNMT 2343/4885
US-20080146469-A1 Process for producing saturated aliphatic hydrocarbon compound, and lubricant composition ALOX15, ALOX12, ALOX15B NPC1 2750/4885RAB9A 4124/4885PNMT 3641/4885
US-20120088946-A1 PROCESS FOR PRODUCING UNSATURATED HYDROCARBON COMPOUND ALOX12, ALOX15B, ALOX15 NPC1 1027/4885RAB9A 4335/4885PNMT 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.